{"id":2741,"date":"2016-01-20T20:51:05","date_gmt":"2016-01-20T20:51:05","guid":{"rendered":"http:\/\/blogs.sld.cu\/oserranob\/?p=2741"},"modified":"2016-01-20T21:40:44","modified_gmt":"2016-01-20T21:40:44","slug":"adn-en-sangre-pronostica-resultados-en-cancer-ginecologico","status":"publish","type":"post","link":"https:\/\/blogs.sld.cu\/oserranob\/2016\/01\/20\/adn-en-sangre-pronostica-resultados-en-cancer-ginecologico\/","title":{"rendered":"ADN en sangre pronostica resultados de c\u00e1ncer ginecol\u00f3gico"},"content":{"rendered":"<p style=\"text-align: justify\"><a href=\"https:\/\/blogs.sld.cu\/oserranob\/files\/2016\/01\/Gynecologic-Ca.png\"><img loading=\"lazy\" class=\"alignleft size-full wp-image-2743\" style=\"border-width: 1px;margin: 5px\" src=\"https:\/\/blogs.sld.cu\/oserranob\/files\/2016\/01\/Gynecologic-Ca.png\" alt=\"Gynecologic Ca\" width=\"108\" height=\"96\" \/><\/a>El ADN tumoral circulante en sangre perif\u00e9rica podr\u00eda ser un biomarcador \u00fatil de la respuesta al tratamiento y la posible enfermedad residual en <a title=\"Informaci\u00f3n sobre la enfermedad en OMIM\" href=\"http:\/\/omim.org\/entry\/167000\" target=\"_blank\">tumores malignos de ovario<\/a> y <a title=\"Informaci\u00f3n sobre la enfermedad en OMIM\" href=\"http:\/\/omim.org\/entry\/603956\" target=\"_blank\">endometrio<\/a>. Tal es la conclusi\u00f3n de Pereira E, Camacho-Vanegas O, Anand S, Sebra R, Catalina Camacho S, Garnar-Wortzel L, <em>et al<\/em>. <a title=\"Texto completo en ingl\u00e9s\" href=\"http:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0145754\" target=\"_blank\">Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers<\/a>. PLoS ONE 2015;10(12):e0145754.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>El ADN tumoral circulante en sangre perif\u00e9rica podr\u00eda ser un biomarcador \u00fatil de la respuesta al tratamiento y la posible enfermedad residual en tumores malignos de ovario y endometrio. Tal es la conclusi\u00f3n de Pereira E, Camacho-Vanegas O, Anand S, Sebra R, Catalina Camacho S, Garnar-Wortzel L, et al. Personalized Circulating Tumor DNA Biomarkers Dynamically [&hellip;]<\/p>\n","protected":false},"author":125,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[11,15],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/2741"}],"collection":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/comments?post=2741"}],"version-history":[{"count":3,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/2741\/revisions"}],"predecessor-version":[{"id":2776,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/2741\/revisions\/2776"}],"wp:attachment":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/media?parent=2741"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/categories?post=2741"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/tags?post=2741"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}